Che Fengrui, Hu Junyuan, Liao Minghong, Luo Zhongfu, Long Hongyan, Li Benpeng, Chi Yonggui Robin, Wu Xingxing
State Key Laboratory of Green Pesticide, Key Laboratory of Green Pesticide and Agricultural Bioengineering, Ministry of Education, Guizhou University, Huaxi District, Guiyang 550025, China.
Institute of Advanced Synthesis, School of Chemistry and Molecular Engineering, Jiangsu National Synergetic Innovation Center for Advanced Materials, Nanjing Tech University, Nanjing 211816, China.
J Am Chem Soc. 2024 Dec 11;146(49):33763-33773. doi: 10.1021/jacs.4c11956. Epub 2024 Nov 26.
Enantioenriched phosphorus(V)-stereogenic compounds, featuring a pentavalent phosphorus atom as the stereogenic center, are crucial in various natural products, drugs, bioactive molecules, and catalysts/ligands. While a handful of stereoselective synthetic approaches have been developed, achieving direct stereocontrol at the phosphorus atom through catalytic generation of phosphorus(V)-heteroatom bonds continues to be a formidable challenge. Here, we disclose an organocatalytic asymmetric condensation strategy that employs a novel activation mode of stable feedstock phosphinic acids by the formation of mixed phosphinic anhydride as the reactive species to facilitate further catalyst-controlled asymmetric P-O bond formations, involving a dynamic kinetic asymmetric transformation (DYKAT) process with alcohol nucleophiles via a cinchonidine-derived bifunctional catalyst. The resulting H-phosphinate intermediates allow further stereospecific derivatizations, affording modular access to a diverse library of chiral phosphonates and phosphonamidates with notable antibacterial activity. Furthermore, this synthetic platform facilitates P-O/N coupling with various natural products and drugs, presenting a valuable tool for medicine and agrochemical discovery.
对映体富集的磷(V)-手性化合物以五价磷原子作为手性中心,在各种天然产物、药物、生物活性分子以及催化剂/配体中至关重要。虽然已经开发了一些立体选择性合成方法,但通过催化生成磷(V)-杂原子键在磷原子上实现直接立体控制仍然是一个巨大的挑战。在此,我们披露了一种有机催化不对称缩合策略,该策略通过形成混合次膦酸酐作为反应物种,采用稳定原料次膦酸的新型活化模式,以促进进一步的催化剂控制的不对称P-O键形成,这涉及通过辛可尼定衍生的双功能催化剂与醇亲核试剂进行的动态动力学不对称转化(DYKAT)过程。所得的次膦酸酯中间体允许进一步的立体特异性衍生化,从而提供模块化途径来获得具有显著抗菌活性的各种手性膦酸酯和膦酰胺酯库。此外,这个合成平台促进了与各种天然产物和药物的P-O/N偶联,为医药和农药发现提供了一个有价值的工具。